The leaders in the business of weight-loss drugs, Novo Nordisk and Eli Lilly, are fighting on a number of fronts to get Medicare officials to pay for the popular medicines.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.